(Q38244795)

31 August 2017

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. (English)

1 reference

31 August 2017

1 reference

acute coronary syndrome

1 reference

24

Julinda Mehilli

0 references

Christian Sticherling

Christian Sticherling

21

0 references

Paulus Kirchhof

Paulus Kirchhof

7

0 references

Marco Valgimigli

Marco Valgimigli

14

0 references

Gregory Lip

18

Gregory Y H Lip

1 reference

31 August 2017

8

Karl-Heinz Kuck

1 reference

31 August 2017

5

Gerhard Hindricks

1 reference

31 August 2017

23

Petr Widimsky

1 reference

31 August 2017

29

Deirdre Lane

1 reference

31 August 2017

20

Laurent Fauchier

1 reference

31 August 2017

1

Bulent Gorenek

1 reference

31 August 2017

4

A John Camm

1 reference

Carina Blomström-Lundqvist

31 August 2017

2

Carina Blomström Lundqvist

1 reference

31 August 2017

17

Uwe Zeymer

1 reference

31 August 2017

Gulmira Kudaiberdieva

9

Gulmira Kudaiberdieva

1 reference

31 August 2017

15

Marc A Vos

1 reference

31 August 2017

22

Marco Roffi

1 reference

31 August 2017

25

Maddalena Lettino

1 reference

31 August 2017

11

Antonio Raviele

1 reference

31 August 2017

Josep Brugada Terradellas

3

1 reference

31 August 2017

Kurt Huber

6

1 reference

31 August 2017

Tina Lin

10

1 reference

31 August 2017

Massimo Santini

12

1 reference

31 August 2017

Roland Richard Tilz

13

1 reference

31 August 2017

Christian Vrints

16

1 reference

31 August 2017

Tatjania Potpara

19

1 reference

31 August 2017

Francois Schiele

26

1 reference

31 August 2017

Peter Sinnaeve

27

1 reference

31 August 2017

Giueseppe Boriani

28

1 reference

31 August 2017

Irene Savelieva

30

1 reference

31 August 2017

29 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

16

1 reference

31 August 2017

1655-1673

1 reference

31 August 2017

11

1 reference

Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction

31 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Primary prevention of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

A tale of coronary artery disease and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Predictors of hospital mortality in the global registry of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Risk score comparison of outcomes in patients presenting with ST-elevation myocardial infarction treated with percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Randomized Trial of Preventive Angioplasty in Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUST

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Flecainide acetate for the treatment of atrial and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Pharmacokinetics and antiarrhythmic efficacy of intravenous ajmaline in ventricular arrhythmia of acute onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Increased mortality after dronedarone therapy for severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The risk of sudden cardiac death in patients with non-ST elevation acute coronary syndrome and prolonged QTc interval: effect of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Electrical storm in patients with an implanted defibrillator: a matter of definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Enhanced detection criteria in implantable defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (H

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Catheter ablation of ventricular fibrillation triggers and electrical storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); Results of the primary PCI registry of the Arbeitsgemeinschaft Leit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Emergency extracorporeal membrane oxygenation in a hospital without on-site cardiac surgical facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Using extracorporeal membrane oxygenation to rescue acute myocardial infarction with cardiopulmonary collapse: the impact of early coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Results of Extracorporeal Membrane Oxygenation (ECMO) Support before Coronary Reperfusion in Cardiogenic Shock with Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Guidelines on myocardial revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Intraaortic balloon support for myocardial infarction with cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Intravenous amiodarone bolus for treatment of atrial fibrillation in patients with advanced congestive heart failure or cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Atrial fibrillation and death after myocardial infarction: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Warfarin, aspirin, or both after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Temporary transvenous cardiac pacing: 6 years experience in one coronary care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

A guide to temporary pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

21 January 2018

Temporary cardiac pacing

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Comparison of antero-lateral versus antero-posterior electrode position for biphasic external cardioversion of atrial flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Part 6: Defibrillation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Causes of death and re‐hospitalization in cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU208

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUU208

1 reference

31 August 2017

1 reference